載入...
Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8<sup>+</sup> T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy
Oncolytic virotherapy has garnered attention as an antigen-agnostic therapeutic cancer vaccine that induces cancer-specific T cell responses without additional antigen loading. As anticancer immune responses are compromised by a lack of antigenicity and chronic immunosuppressive microenvironments, a...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
MDPI AG
2022-03-01
|
叢編: | Biomedicines |
主題: | |
在線閱讀: | https://www.mdpi.com/2227-9059/10/4/805 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|